Intersect ENT (XENT) Reports Q3 Loss, Lags Revenue Estimates
Intersect ENT (XENT) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.34 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report…
